Aleksandra Gentry-Maharaj is a Principal Research Fellow, based both at the Institute of Clinical Trials and Methodology (ICTM) and the Institute for Women’s Health (IfWH). Since August 2023, she has been the Head of the Research Department of Women’s Cancer (IfWH). She joined the Gynaecological Cancer Research Centre as a Research Associate in 2003, first based at Barts and, since April 2004, at the Institute for Women's Health. Throughout her entire appointment at UCL, she was key to the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Since 2006, she has co-set up and coordinated the UK Ovarian Cancer Population (UKOPS) study. Since 2017, she has taken on the role of the UKCTOCS Project Lead and, since 2021, the role of the ICON8B and Add-Aspirin Project Co-lead. Alex took on the role of the CRUK ACED Co-Director of Research Domain Trials in 2022. In 2023, she joined the Steering Committee of the International 100K+ Cohort Consortium. She is the author of more than 205 papers in high-impact journals and has contributed to numerous textbooks and reviews. She is an Editor for BMC Women’s Health and Diagnostics. She has presented her work at national and key international meetings (ESGO Istanbul 2005, IGCS Santa Monica 2006, ESGO Berlin 2007, IMS Madrid 2008, ESGO Nice 2015, and BGCS, amongst others).